These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 29283077)

  • 1. Species distribution, sequence types and antimicrobial resistance of Acinetobacter spp. from cystic fibrosis patients.
    Rocha GA; Lima DF; Rodrigues ER; Leão RS; Folescu TW; Firmida MC; Cohen RWF; Albano RM; Marques EA
    Epidemiol Infect; 2018 Mar; 146(4):524-530. PubMed ID: 29283077
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence and antimicrobial susceptibility of Acinetobacter spp. isolated from meat.
    Carvalheira A; Casquete R; Silva J; Teixeira P
    Int J Food Microbiol; 2017 Feb; 243():58-63. PubMed ID: 27992816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characteristics of carbapenem-resistant Acinetobacter spp. other than Acinetobacter baumannii in South Korea.
    Park YK; Jung SI; Park KH; Kim SH; Ko KS
    Int J Antimicrob Agents; 2012 Jan; 39(1):81-5. PubMed ID: 21996405
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular Epidemiology and Clinical Impact of Acinetobacter calcoaceticus-baumannii Complex in a Belgian Burn Wound Center.
    De Vos D; Pirnay JP; Bilocq F; Jennes S; Verbeken G; Rose T; Keersebilck E; Bosmans P; Pieters T; Hing M; Heuninckx W; De Pauw F; Soentjens P; Merabishvili M; Deschaght P; Vaneechoutte M; Bogaerts P; Glupczynski Y; Pot B; van der Reijden TJ; Dijkshoorn L
    PLoS One; 2016; 11(5):e0156237. PubMed ID: 27223476
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms of carbapenem resistance in Acinetobacter pittii and Acinetobacter nosocomialis isolates from Thailand.
    Singkham-In U; Chatsuwan T
    J Med Microbiol; 2018 Dec; 67(12):1667-1672. PubMed ID: 30311872
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of carbapenem-resistant Acinetobacter baumannii in Brazil (2008-2011): countrywide spread of OXA-23-producing clones (CC15 and CC79).
    Chagas TP; Carvalho KR; de Oliveira Santos IC; Carvalho-Assef AP; Asensi MD
    Diagn Microbiol Infect Dis; 2014 Aug; 79(4):468-72. PubMed ID: 24880823
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular Epidemiology of Emerging Carbapenem Resistance in
    Chen FJ; Huang WC; Liao YC; Wang HY; Lai JF; Kuo SC; Lauderdale TL; Sytwu HK
    Antimicrob Agents Chemother; 2019 Apr; 63(4):. PubMed ID: 30670429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidemiological characterizations of class 1 integrons from multidrug-resistant acinetobacter isolates in Daejeon, Korea.
    Sung JY; Koo SH; Kim S; Kwon KC
    Ann Lab Med; 2014 Jul; 34(4):293-9. PubMed ID: 24982834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pneumonia caused by extensive drug-resistant Acinetobacter baumannii among hospitalized patients: genetic relationships, risk factors and mortality.
    Li YJ; Pan CZ; Fang CQ; Zhao ZX; Chen HL; Guo PH; Zhao ZW
    BMC Infect Dis; 2017 May; 17(1):371. PubMed ID: 28558660
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The emergence of a novel sequence type of MDR Acinetobacter baumannii from the intensive care unit of an Egyptian tertiary care hospital.
    Ghaith DM; Zafer MM; Al-Agamy MH; Alyamani EJ; Booq RY; Almoazzamy O
    Ann Clin Microbiol Antimicrob; 2017 May; 16(1):34. PubMed ID: 28486994
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular characterization of carbapenem-non-susceptible Acinetobacter spp. in Japan: predominance of multidrug-resistant Acinetobacter baumannii clonal complex 92 and IMP-type metallo-β-lactamase-producing non-baumannii Acinetobacter species.
    Kouyama Y; Harada S; Ishii Y; Saga T; Yoshizumi A; Tateda K; Yamaguchi K
    J Infect Chemother; 2012 Aug; 18(4):522-8. PubMed ID: 22327516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular epidemiology, antimicrobial susceptibility and carbapenemase resistance determinants among Acinetobacter baumannii clinical isolates in Taiwan.
    Chuang YC; Sheng WH; Lauderdale TL; Li SY; Wang JT; Chen YC; Chang SC
    J Microbiol Immunol Infect; 2014 Aug; 47(4):324-32. PubMed ID: 23726465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular epidemiology of Acinetobacter baumannii and Acinetobacter nosocomialis in Germany over a 5-year period (2005-2009).
    Schleicher X; Higgins PG; Wisplinghoff H; Körber-Irrgang B; Kresken M; Seifert H
    Clin Microbiol Infect; 2013 Aug; 19(8):737-42. PubMed ID: 23034071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical outcomes of hospital-acquired infection with Acinetobacter nosocomialis and Acinetobacter pittii.
    Chusri S; Chongsuvivatwong V; Rivera JI; Silpapojakul K; Singkhamanan K; McNeil E; Doi Y
    Antimicrob Agents Chemother; 2014 Jul; 58(7):4172-9. PubMed ID: 24820079
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular epidemiology of multidrug-resistant Acinetobacter baumannii isolates in a university hospital in Nepal reveals the emergence of a novel epidemic clonal lineage.
    Shrestha S; Tada T; Miyoshi-Akiyama T; Ohara H; Shimada K; Satou K; Teruya K; Nakano K; Shiroma A; Sherchand JB; Rijal BP; Hirano T; Kirikae T; Pokhrel BM
    Int J Antimicrob Agents; 2015 Nov; 46(5):526-31. PubMed ID: 26362951
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antimicrobial susceptibility patterns and distribution of blaOXA genes among Acinetobacter spp. Isolated from patients at Tehran hospitals.
    Feizabadi MM; Fathollahzadeh B; Taherikalani M; Rasoolinejad M; Sadeghifard N; Aligholi M; Soroush S; Mohammadi-Yegane S
    Jpn J Infect Dis; 2008 Jul; 61(4):274-8. PubMed ID: 18653968
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emergence of NDM-producing non-baumannii Acinetobacter spp. isolated from China.
    Zhang R; Hu YY; Yang XF; Gu DX; Zhou HW; Hu QF; Zhao K; Yu SF; Chen GX
    Eur J Clin Microbiol Infect Dis; 2014 May; 33(5):853-60. PubMed ID: 24306098
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Imported and intensive care unit-born Acinetobacter baumannii clonal complexes: one-year prospective cohort study in intensive care patients.
    Martins N; Martins IS; de Freitas WV; de Matos JA; Girão VB; Coelho-Souza T; Maralhães AC; Cacci LC; de Figueiredo MP; Dias RC; Costa-Lourenço AP; Ferreira AL; Dalla-Costa L; Nouér SA; Santoro-Lopes G; Riley LW; Moreira BM
    Microb Drug Resist; 2013 Jun; 19(3):216-23. PubMed ID: 23336529
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distribution of carbapenem resistance determinants among epidemic and non-epidemic types of Acinetobacter species in Japan.
    Matsui M; Suzuki S; Yamane K; Suzuki M; Konda T; Arakawa Y; Shibayama K
    J Med Microbiol; 2014 Jun; 63(Pt 6):870-877. PubMed ID: 24600014
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High prevalence of the PER-1 gene among carbapenem-resistant Acinetobacter baumannii in Riyadh, Saudi Arabia.
    Aly MM; Abu Alsoud NM; Elrobh MS; Al Johani SM; Balkhy HH
    Eur J Clin Microbiol Infect Dis; 2016 Nov; 35(11):1759-1766. PubMed ID: 27527351
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.